- •Preface
- •Acknowledgments
- •Contents
- •1.1 Introduction
- •1.2 Normal Embryology
- •1.3 Abnormalities of the Kidney
- •1.3.1 Renal Agenesis
- •1.3.2 Renal Hypoplasia
- •1.3.3 Supernumerary Kidneys
- •1.3.5 Polycystic Kidney Disease
- •1.3.6 Simple (Solitary) Renal Cyst
- •1.3.7 Renal Fusion and Renal Ectopia
- •1.3.8 Horseshoe Kidney
- •1.3.9 Crossed Fused Renal Ectopia
- •1.4 Abnormalities of the Ureter
- •1.5 Abnormalities of the Bladder
- •1.6 Abnormalities of the Penis and Urethra in Males
- •1.7 Abnormalities of Female External Genitalia
- •Further Reading
- •2.1 Introduction
- •2.2 Pathophysiology
- •2.3 Etiology of Hydronephrosis
- •2.5 Clinical Features
- •2.6 Investigations and Diagnosis
- •2.7 Treatment
- •2.8 Antenatal Hydronephrosis
- •Further Reading
- •3.1 Introduction
- •3.2 Embryology
- •3.3 Pathophysiology
- •3.4 Etiology of PUJ Obstruction
- •3.5 Clinical Features
- •3.6 Diagnosis and Investigations
- •3.7 Management of Newborns with PUJ Obstruction
- •3.8 Treatment
- •3.9 Post-operative Complications and Follow-Up
- •Further Reading
- •4: Renal Tumors in Children
- •4.1 Introduction
- •4.2 Wilms’ Tumor
- •4.2.1 Introduction
- •4.2.2 Etiology
- •4.2.3 Histopathology
- •4.2.4 Nephroblastomatosis
- •4.2.5 Clinical Features
- •4.2.6 Risk Factors for Wilms’ Tumor
- •4.2.7 Staging of Wilms Tumor
- •4.2.8 Investigations
- •4.2.9 Prognosis and Complications of Wilms Tumor
- •4.2.10 Surgical Considerations
- •4.2.11 Surgical Complications
- •4.2.12 Prognosis and Outcome
- •4.2.13 Extrarenal Wilms’ Tumors
- •4.3 Mesoblastic Nephroma
- •4.3.1 Introduction
- •4.3.3 Epidemiology
- •4.3.5 Clinical Features
- •4.3.6 Investigations
- •4.3.7 Treatment and Prognosis
- •4.4 Clear Cell Sarcoma of the Kidney (CCSK)
- •4.4.1 Introduction
- •4.4.2 Pathophysiology
- •4.4.3 Clinical Features
- •4.4.4 Investigations
- •4.4.5 Histopathology
- •4.4.6 Treatment
- •4.4.7 Prognosis
- •4.5 Malignant Rhabdoid Tumor of the Kidney
- •4.5.1 Introduction
- •4.5.2 Etiology and Pathophysiology
- •4.5.3 Histologic Findings
- •4.5.4 Clinical Features
- •4.5.5 Investigations and Diagnosis
- •4.5.6 Treatment and Outcome
- •4.5.7 Mortality/Morbidity
- •4.6 Renal Cell Carcinoma in Children
- •4.6.1 Introduction
- •4.6.2 Histopathology
- •4.6.4 Staging
- •4.6.5 Clinical Features
- •4.6.6 Investigations
- •4.6.7 Management
- •4.6.8 Prognosis
- •4.7 Angiomyolipoma of the Kidney
- •4.7.1 Introduction
- •4.7.2 Histopathology
- •4.7.4 Clinical Features
- •4.7.5 Investigations
- •4.7.6 Treatment and Prognosis
- •4.8 Renal Lymphoma
- •4.8.1 Introduction
- •4.8.2 Etiology and Pathogenesis
- •4.8.3 Diagnosis
- •4.8.4 Clinical Features
- •4.8.5 Treatment and Prognosis
- •4.9 Ossifying Renal Tumor of Infancy
- •4.10 Metanephric Adenoma
- •4.10.1 Introduction
- •4.10.2 Histopathology
- •4.10.3 Diagnosis
- •4.10.4 Clinical Features
- •4.10.5 Treatment
- •4.11 Multilocular Cystic Renal Tumor
- •Further Reading
- •Wilms’ Tumor
- •Mesoblastic Nephroma
- •Renal Cell Carcinoma in Children
- •Angiomyolipoma of the Kidney
- •Renal Lymphoma
- •Ossifying Renal Tumor of Infancy
- •Metanephric Adenoma
- •Multilocular Cystic Renal Tumor
- •5.1 Introduction
- •5.2 Embryology
- •5.4 Histologic Findings
- •5.7 Associated Anomalies
- •5.8 Clinical Features
- •5.9 Investigations
- •5.10 Treatment
- •Further Reading
- •6: Congenital Ureteral Anomalies
- •6.1 Etiology
- •6.2 Clinical Features
- •6.3 Investigations and Diagnosis
- •6.4 Duplex (Duplicated) System
- •6.4.1 Introduction
- •6.4.3 Clinical Features
- •6.4.4 Investigations
- •6.4.5 Treatment and Prognosis
- •6.5 Ectopic Ureter
- •6.5.1 Introduction
- •6.5.3 Clinical Features
- •6.5.4 Diagnosis
- •6.5.5 Surgical Treatment
- •6.6 Ureterocele
- •6.6.1 Introduction
- •6.6.3 Clinical Features
- •6.6.4 Investigations and Diagnosis
- •6.6.5 Treatment
- •6.6.5.1 Surgical Interventions
- •6.8 Mega Ureter
- •Further Reading
- •7: Congenital Megaureter
- •7.1 Introduction
- •7.3 Etiology and Pathophysiology
- •7.4 Clinical Presentation
- •7.5 Investigations and Diagnosis
- •7.6 Treatment and Prognosis
- •7.7 Complications
- •Further Reading
- •8.1 Introduction
- •8.2 Pathophysiology
- •8.4 Etiology of VUR
- •8.5 Clinical Features
- •8.6 Investigations
- •8.7 Management
- •8.7.1 Medical Treatment of VUR
- •8.7.2 Antibiotics Used for Prophylaxis
- •8.7.3 Anticholinergics
- •8.7.4 Surveillance
- •8.8 Surgical Therapy of VUR
- •8.8.1 Indications for Surgical Interventions
- •8.8.2 Indications for Surgical Interventions Based on Age at Diagnosis and the Presence or Absence of Renal Lesions
- •8.8.3 Endoscopic Injection
- •8.8.4 Surgical Management
- •8.9 Mortality/Morbidity
- •Further Reading
- •9: Pediatric Urolithiasis
- •9.1 Introduction
- •9.2 Etiology
- •9.4 Clinical Features
- •9.5 Investigations
- •9.6 Complications of Urolithiasis
- •9.7 Management
- •Further Reading
- •10.1 Introduction
- •10.2 Embryology of Persistent Müllerian Duct Syndrome
- •10.3 Etiology and Inheritance of PMDS
- •10.5 Clinical Features
- •10.6 Treatment
- •10.7 Prognosis
- •Further Reading
- •11.1 Introduction
- •11.2 Physiology and Bladder Function
- •11.2.1 Micturition
- •11.3 Pathophysiological Changes of NBSD
- •11.4 Etiology and Clinical Features
- •11.5 Investigations and Diagnosis
- •11.7 Management
- •11.8 Clean Intermittent Catheterization
- •11.9 Anticholinergics
- •11.10 Botulinum Toxin Type A
- •11.11 Tricyclic Antidepressant Drugs
- •11.12 Surgical Management
- •Further Reading
- •12.1 Introduction
- •12.2 Etiology
- •12.3 Pathophysiology
- •12.4 Clinical Features
- •12.5 Investigations and Diagnosis
- •12.6 Management
- •Further Reading
- •13.1 Introduction
- •13.2 Embryology
- •13.3 Epispadias
- •13.3.1 Introduction
- •13.3.2 Etiology
- •13.3.4 Treatment
- •13.3.6 Female Epispadias
- •13.3.7 Surgical Repair of Female Epispadias
- •13.3.8 Prognosis
- •13.4 Bladder Exstrophy
- •13.4.1 Introduction
- •13.4.2 Associated Anomalies
- •13.4.3 Principles of Surgical Management of Bladder Exstrophy
- •13.4.4 Evaluation and Management
- •13.5 Cloacal Exstrophy
- •13.5.1 Introduction
- •13.5.2 Skeletal Changes in Cloacal Exstrophy
- •13.5.3 Etiology and Pathogenesis
- •13.5.4 Prenatal Diagnosis
- •13.5.5 Associated Anomalies
- •13.5.8 Surgical Reconstruction
- •13.5.9 Management of Urinary Incontinence
- •13.5.10 Prognosis
- •13.5.11 Complications
- •Further Reading
- •14.1 Introduction
- •14.2 Etiology
- •14.3 Clinical Features
- •14.4 Associated Anomalies
- •14.5 Diagnosis
- •14.6 Treatment and Prognosis
- •Further Reading
- •15: Cloacal Anomalies
- •15.1 Introduction
- •15.2 Associated Anomalies
- •15.4 Clinical Features
- •15.5 Investigations
- •Further Reading
- •16: Urachal Remnants
- •16.1 Introduction
- •16.2 Embryology
- •16.4 Clinical Features
- •16.5 Tumors and Urachal Remnants
- •16.6 Management
- •Further Reading
- •17: Inguinal Hernias and Hydroceles
- •17.1 Introduction
- •17.2 Inguinal Hernia
- •17.2.1 Incidence
- •17.2.2 Etiology
- •17.2.3 Clinical Features
- •17.2.4 Variants of Hernia
- •17.2.6 Treatment
- •17.2.7 Complications of Inguinal Herniotomy
- •17.3 Hydrocele
- •17.3.1 Embryology
- •17.3.3 Treatment
- •Further Reading
- •18: Cloacal Exstrophy
- •18.1 Introduction
- •18.2 Etiology and Pathogenesis
- •18.3 Associated Anomalies
- •18.4 Clinical Features and Management
- •Further Reading
- •19: Posterior Urethral Valve
- •19.1 Introduction
- •19.2 Embryology
- •19.3 Pathophysiology
- •19.5 Clinical Features
- •19.6 Investigations and Diagnosis
- •19.7 Management
- •19.8 Medications Used in Patients with PUV
- •19.10 Long-Term Outcomes
- •19.10.3 Bladder Dysfunction
- •19.10.4 Renal Transplantation
- •19.10.5 Fertility
- •Further Reading
- •20.1 Introduction
- •20.2 Embryology
- •20.4 Clinical Features
- •20.5 Investigations
- •20.6 Treatment
- •20.7 The Müllerian Duct Cyst
- •Further Reading
- •21: Hypospadias
- •21.1 Introduction
- •21.2 Effects of Hypospadias
- •21.3 Embryology
- •21.4 Etiology of Hypospadias
- •21.5 Associated Anomalies
- •21.7 Clinical Features of Hypospadias
- •21.8 Treatment
- •21.9 Urinary Diversion
- •21.10 Postoperative Complications
- •Further Reading
- •22: Male Circumcision
- •22.1 Introduction
- •22.2 Anatomy and Pathophysiology
- •22.3 History of Circumcision
- •22.4 Pain Management
- •22.5 Indications for Circumcision
- •22.6 Contraindications to Circumcision
- •22.7 Surgical Procedure
- •22.8 Complications of Circumcision
- •Further Reading
- •23: Priapism in Children
- •23.1 Introduction
- •23.2 Pathophysiology
- •23.3 Etiology
- •23.5 Clinical Features
- •23.6 Investigations
- •23.7 Management
- •23.8 Prognosis
- •23.9 Priapism and Sickle Cell Disease
- •23.9.1 Introduction
- •23.9.2 Epidemiology
- •23.9.4 Pathophysiology
- •23.9.5 Clinical Features
- •23.9.6 Treatment
- •23.9.7 Prevention of Stuttering Priapism
- •23.9.8 Complications of Priapism and Prognosis
- •Further Reading
- •24.1 Introduction
- •24.2 Embryology and Normal Testicular Development and Descent
- •24.4 Causes of Undescended Testes and Risk Factors
- •24.5 Histopathology
- •24.7 Clinical Features and Diagnosis
- •24.8 Treatment
- •24.8.1 Success of Surgical Treatment
- •24.9 Complications of Orchidopexy
- •24.10 Infertility and Undescended Testes
- •24.11 Undescended Testes and the Risk of Cancer
- •Further Reading
- •25: Varicocele
- •25.1 Introduction
- •25.2 Etiology
- •25.3 Pathophysiology
- •25.4 Grading of Varicoceles
- •25.5 Clinical Features
- •25.6 Diagnosis
- •25.7 Treatment
- •25.8 Postoperative Complications
- •25.9 Prognosis
- •Further Reading
- •26.1 Introduction
- •26.2 Etiology and Risk Factors
- •26.3 Diagnosis
- •26.4 Intermittent Testicular Torsion
- •26.6 Effects of Testicular Torsion
- •26.7 Clinical Features
- •26.8 Treatment
- •26.9.1 Introduction
- •26.9.2 Etiology of Extravaginal Torsion
- •26.9.3 Clinical Features
- •26.9.4 Treatment
- •26.10 Torsion of the Testicular or Epididymal Appendage
- •26.10.1 Introduction
- •26.10.2 Embryology
- •26.10.3 Clinical Features
- •26.10.4 Investigations and Treatment
- •Further Reading
- •27: Testicular Tumors in Children
- •27.1 Introduction
- •27.4 Etiology of Testicular Tumors
- •27.5 Clinical Features
- •27.6 Staging
- •27.6.1 Regional Lymph Node Staging
- •27.7 Investigations
- •27.8 Treatment
- •27.9 Yolk Sac Tumor
- •27.10 Teratoma
- •27.11 Mixed Germ Cell Tumor
- •27.12 Stromal Tumors
- •27.13 Simple Testicular Cyst
- •27.14 Epidermoid Cysts
- •27.15 Testicular Microlithiasis (TM)
- •27.16 Gonadoblastoma
- •27.17 Cystic Dysplasia of the Testes
- •27.18 Leukemia and Lymphoma
- •27.19 Paratesticular Rhabdomyosarcoma
- •27.20 Prognosis and Outcome
- •Further Reading
- •28: Splenogonadal Fusion
- •28.1 Introduction
- •28.2 Etiology
- •28.4 Associated Anomalies
- •28.5 Clinical Features
- •28.6 Investigations
- •28.7 Treatment
- •Further Reading
- •29: Acute Scrotum
- •29.1 Introduction
- •29.2 Torsion of Testes
- •29.2.1 Introduction
- •29.2.3 Etiology
- •29.2.4 Clinical Features
- •29.2.5 Effects of Torsion of Testes
- •29.2.6 Investigations
- •29.2.7 Treatment
- •29.3 Torsion of the Testicular or Epididymal Appendage
- •29.3.1 Introduction
- •29.3.2 Embryology
- •29.3.3 Clinical Features
- •29.3.4 Investigations and Treatment
- •29.4.1 Introduction
- •29.4.2 Etiology
- •29.4.3 Clinical Features
- •29.4.4 Investigations and Treatment
- •29.5 Idiopathic Scrotal Edema
- •29.6 Testicular Trauma
- •29.7 Other Causes of Acute Scrotum
- •29.8 Splenogonadal Fusion
- •Further Reading
- •30.1 Introduction
- •30.2 Imperforate Hymen
- •30.3 Vaginal Atresia
- •30.5 Associated Anomalies
- •30.6 Embryology
- •30.7 Clinical Features
- •30.8 Investigations
- •30.9 Management
- •Further Reading
- •31: Disorders of Sexual Development
- •31.1 Introduction
- •31.2 Embryology
- •31.3 Sexual and Gonadal Differentiation
- •31.5 Evaluation of a Newborn with DSD
- •31.6 Diagnosis and Investigations
- •31.7 Management of Patients with DSD
- •31.8 Surgical Corrections of DSD
- •31.9 Congenital Adrenal Hyperplasia (CAH)
- •31.10 Androgen Insensitivity Syndrome (Testicular Feminization Syndrome)
- •31.13 Gonadal Dysgenesis
- •31.15 Ovotestis Disorders of Sexual Development
- •31.16 Other Rare Disorders of Sexual Development
- •Further Reading
- •Index
Further Reading |
41 |
|
|
Fig. 1.91 A clinical photogram showing dermoid cyst of the clitoris which can be confused with cliteromegaly
–Clinically, a round doughnut-shaped mucosa is seen protruding from the urethral opening.
–Management of urethral prolapse ranges from medical therapy that consists of topical estrogen use to conservative surgical excision when medical therapies fail.
Congenital Abnormalities of the Female
External Genitalia and Urethra
•Distal urethral stenosis
•Labial fusion
•Clitoral hypertrophy
•Urethral prolapse
Further Reading
1. Bertram JF, Douglas-Denton RN, et al. Human nephron number: implications for health and disease. Pediatr Nephrol. 2011;26:1529–33.
2. Caiulo VA, Caiulo S, Gargasole C, et al. Ultrasound mass screening for congenital anomalies of the kidney and urinary tract. Pediatr Nephrol. 2012;27:949.
3.Chowdhary SK, Lander A, Parashar K, Corkery JJ. Single-system ectopic ureter: a 15-year review. Pediatr Surg Int. 2001;17(8):638–41.
4.Daneman A, Alton DJ. Radiographic manifestations
of renal anomalies. Radiol Clin North Am. 1991;29(2):351–63.
5. Decter RM. Renal duplication and fusion anomalies. Pediatr Clin North Am. 1997;44:1323.
6. Glassberg KI. Normal and abnormal development of the kidney: a clinician’s interpretation of current knowledge. J Urol. 2002;167:2339.
7. Gribouval O, Gonzales M, Neuhaus T, et al. Mutations in genes in the renin-angiotensin system are associated with autosomal recessive renal tubular dysgenesis. Nat Genet. 2005;37:964.
8.Gubler MC. Renal tubular dysgenesis. Pediatr Nephrol. 2014;29:51.
9. Harris J, Robert E, Källén B. Epidemiologic characteristics of kidney malformations. Eur J Epidemiol. 2000;16:985.
10. Kluth D, Fiegel HC, Geyer C, et al. Embryology of the distal urethra and external genitals. Semin Pediatr Surg. 2011;20:176–87.
11. Krishnan A, de Souza A, Konijeti R, et al. The anatomy and embryology of posterior urethral valves. J Urol. 2006;175:1214–20.
12.Nakai H, Asanuma H, Shishido S, Kitahara S, Yasuda K. Changing concepts in urological management of the congenital anomalies of kidney and urinary tract, CAKUT. Pediatr Int. 2003;45(5):634–41.
13.Piscione TD, Rosenblum ND. The malformed kidney: disruption of glomerular and tubular development.
Clin Genet. 1999;56:341.
14. Sanna-Cherchi S, Caridi G, Weng PL, et al. Genetic approaches to human renal agenesis/hypoplasia and dysplasia. Pediatr Nephrol. 2007;22:1675.
15. Sanna-Cherchi S, Ravani P, Corbani V, et al. Renal outcome in patients with congenital anomalies of the kidney and urinary tract. Kidney Int. 2009;76:528.
16.Schedl A. Renal abnormalities and their developmental origin. Nat Rev Genet. 2007;8(10):791–802.
17. Seikaly MG, Ho PL, Emmett L, et al. Chronic renal insufficiency in children: the 2001 annual report of the NAPRTCS. Pediatr Nephrol. 2003;18:796.
18.Shnorhavorian M, Bittner R, Wright JL, Schwartz SM. Maternal risk factors for congenital urinary anomalies: results of a population-based case-control study. Urology. 2011;78:1156.
19.Song R, Yosypiv IV. Genetics of congenital anomalies of the kidney and urinary tract. Pediatr Nephrol. 2011;26(3):353–64.
20. Viana R, Batourina E, Huang H, et al. The development of the bladder trigone, the center of the antireflux mechanism. Development. 2007;134:3763–9.
21.Weizer AZ, Silverstein AD, Auge BK, et al. Determining the incidence of horseshoe kidney from radiographic data at a single institution. J Urol.
2003;170(5):1722–6.
22. Westland R, Schreuder MF, Ket JC, van Wijk JA. Unilateral renal agenesis: a systematic review on associated anomalies and renal injury. Nephrol Dial Transplant. 2013;28:1844.
23.Wiesel A, Queisser-Luft A, Clementi M, et al. Prenatal detection of congenital renal malformations by fetal ultrasonographic examination: an analysis of 709,030 births in 12 European countries. Eur J Med Genet. 2005;48(2):131–44.
24.Yavuz S, Kıyak A, Sander S. Renal outcome of children with horseshoe kidney: a single-center experi-
ence. Urology. 2015;85:463.
25. Yiee JH, Baskin LS. Penile embryology and anatomy. Scientific World Journal. 2010;10:1174–9.
26.Zalel Y, Pinhas-Hamiel O, Lipitz S, et al. The development of the fetal penis – an in utero sonographic evaluation. Ultrasound Obstet Gynecol. 2001;17:129–31.
Hydronephrosis in Infants |
2 |
and Children |
2.1Introduction
•The word “hydro” represents “water” and “nephro” represents “kidney”.
•Hydronephrosis means “water inside the kidney”.
•Hydronephrosis is defined as distension and dilation of the renal pelvis and calyces (Figs. 2.1 and 2.2).
•Hydroureteronephrosis refers to distention of both the ureter and the renal pelvis and calices.
•Hydronephrosis is usually caused by obstruction of the free flow of urine from the kidney.
•Hydroureteronephrosis is usually caused by obstruction at the uretrovesical junction or below.
•The signs and symptoms of hydronephrosis depend upon:
–Whether the obstruction is acute or chronic
–Whether the obstruction is partial or complete
–Whether the obstruction is unilateral or bilateral
–Hydronephrosis that occurs acutely with sudden onset can cause intense pain in the flanks (Dietl’s crisis).
•If symptoms occur they can include:
–Back, flank or lower abdominal pain
–Nausea and vomiting
–Dysuria
–Burning during micturition
–Urinary incontinence
–Hematuria
–Febrile urinary tract infections
•Hydronephrosis should be graded accurately in order to make good clinical decisions concerning the management and follow-up.
•There are currently two methods to grade the degree of hydronephrosis:
–The simple classification system of “mild, moderate, and severe” is less accurate.
–The Society for Fetal Urology (SFU) has developed a more accurate numerical grading system for hydronephrosis.
•The causes of hydronephrosis can be congenital or acquired.
•It is important to understand that hydronephrosis does not always mean there is obstruction to the flow of urine from the kidney and hydronephrosis is a secondary effect of some other disease. Thus, the terms hydronephrosis and obstruction should not be used interchangeably.
•With the widespread use of prenatal ultrasounds, antenatal hydronephrosis is currently the most common diagnosed prenatal condition.
•Hydronephrosis can be caused by obstruction anywhere along the upper or lower urinary tract.
–Obstruction that occurs anywhere along the upper urinary tract will lead to increased pressure within the kidney.
–Obstruction occurring in the lower urinary tract can also cause this increased pressure through efflux of urine into the kidney.
© Springer International Publishing Switzerland 2017 |
43 |
A.H. Al-Salem, An Illustrated Guide to Pediatric Urology, DOI 10.1007/978-3-319-44182-5_2 |
|
44 |
2 Hydronephrosis in Infants and Children |
|
|
Figs. 2.1 and 2.2 Intravenous urogram and a micturating cystourethrogram showing bilateral hydronephrosis and unilateral hydroureteronephrosis
– This would eventually lead to: |
|
– In 15 %, the hydronephrosis persists (non- |
||||
|
• |
Urinary tract infection |
|
refluxing, non-obstructing hydronephrosis) |
||
|
• |
Stone formation |
|
|
but spontaneously regress by age 3 years. |
|
|
• Loss of renal function |
|
– In the remaining 35 %, a pathological cause |
|||
• Neonatal hydronephrosis can be caused by |
can be identified. |
|||||
several abnormalities. |
These commonly |
• Extensive use of prenatal ultrasound has led to |
||||
include (Figs. 2.3, 2.4, 2.5, 2.6, 2.7, 2.8, |
an increased rate of diagnosis of neonatal |
|||||
and 2.9): |
|
|
|
hydronephrosis, of which ureteropelvic junc- |
||
– |
Ureteropelvic junction obstruction |
|
tion obstruction is the most frequent cause. |
|||
– |
Vesicoureteral reflux |
|
|
• Ureteropelvic junction obstruction occurs in |
||
– |
Ureterovesical junction obstruction |
|
approximately 1 in every 2,000 live births and |
|||
– |
Megaureter |
|
|
|
accounts for approximately half of the cases |
|
– Ureterovesical |
junction obstruction |
and |
of prenatal hydronephrosis. |
|||
|
megaureter are fairly uncommon and, |
• In most cases, neonatal hydronephrosis second- |
||||
|
therefore, pediatric patients who have |
ary to ureteropelvic junction obstruction gradu- |
||||
|
hydronephrosis and a normal voiding cys- |
ally resolves without surgical intervention. |
||||
|
tourethrogram are presumed to have ure- |
• There is a strong correlation between the Society |
||||
|
teropelvic junction obstruction. |
|
for Fetal Urology (SFU) grade of hydronephrosis |
|||
• Prenatally diagnosed hydronephrosis: |
|
and the likelihood of spontaneous resolution: |
||||
– Approximately |
50 % |
are transient |
and |
– Grade I resolves in approximately 50 % of |
||
|
resolve by the time the infant is born. |
|
patients |
2.2 Pathophysiology |
45 |
|
|
Figs. 2.3 and 2.4 Intravenous urography and micturating cystourethrogram showing pelviureteric junction obstruction and bilateral vesicoureteric reflux
–Grades II resolves in approximately 36 % of patients
–Grade III resolves in approximately 16 % of patients
–Grade IV resolves in approximately 3 % of patients
•The initial severity of the hydronephrosis at the time of antenatal diagnosis and the presence of the hydronephrosis at birth were the only two factors that predicted hydronephrosis failure to resolve.
•Hydronephrosis that was mild to mild-to- moderate in severity resolved in 71 % of patients, compared to 28 % of children with moderate to severe hydronephrosis. This supports the claim that the severity of hydronephrosis predicts failure of the lesion to resolve.
2.2Pathophysiology
•Hydronephrosis can result from anatomic or functional causes that interrupt the flow of urine (Figs. 2.10 and 2.11).
•This interruption can occur anywhere along the urinary tract from the kidneys to the urethral meatus.
•Gross changes within the urinary tract depend on:
–The duration of obstruction
–The degree of obstruction
–The level of obstruction
•Within the intrarenal collecting system, the degree of dilation is limited by surrounding renal parenchyma.
•This is in contrast to the extrarenal components which can dilate to the point of tortuosity.
•Hydronephrosis can reasonably be viewed as a beneficial compensatory mechanism that actually protects the kidney against high intrapelvic pressures and further renal damage.
•The extent and persistence of these functional insults are directly related to the duration and severity of the obstruction.
–Brief disruptions lead to reversible functional disturbances with little associated anatomic changes.
46 |
2 Hydronephrosis in Infants and Children |
|
|
Figs. 2.5 and 2.6 A micturating cystourethrogrma showing severe vesicoureteric reflux in a patient with a duplex system. An intravenous urogram showing a negaureter with hydroureteronephrosis is seen in the second picture.
In patients with megaureter, there is no anatomical obstruction at the uretrovesical junction and micturating cystourethrogram doe not show vesico ureteric reflux
–More chronic disruptions lead to profound tubular atrophy and permanent nephron loss.
•The rise in ureteral or renal pelvic pressure leads to marked changes in glomerular filtration, tubular function, and renal blood flow.
•The glomerular filtration rate (GFR) declines significantly within hours following acute obstruction. This significant decline of GFR can persist for weeks after relief of obstruction.
•In addition, renal tubular ability to transport sodium, potassium, to concentrate and to dilute the urine is severely impaired.
•Increased ureteral pressure also results in pyelovenous and pyelolymphatic backflow.
•Acute hydronephrosis:
–Acute hydronephrosis when corrected, usually allows full recovery of renal function.
–It can be associated with little anatomic disturbance to renal parenchyma.
•Chronic hydronephrosis:
–In chronic hydronephrosis, the loss of function is usually irreversible even with correction of the obstruction.
–It may be associated with compression of the papillae, thinning of the renal parenchyma around the calyces, and coalescence of the septa between calyces.
–Eventually, cortical atrophy progresses to the point at which only a thin rim of parenchyma is present (Figs. 2.12, 2.13, and 2.14).
–Microscopic changes consist of dilation of the tubular lumen and flattening of the tubular epithelium. Fibrotic changes and increased collagen deposition are observed in the peritubular interstitial tissue.
2.2 Pathophysiology |
47 |
|
|
STENOSED
URETER
SEGMENT DILATED URETER
DILATED
URETER
STENOSED
URETER
SEGMENT
Figs. 2.7, 2.8, and 2.9 An intravenous urogram showing hydrouretronephrosis secondary to obstruction at the uretrovesical junction. Note the ureter tappering at the lower part. This was confirmed intraoperatively in the second
two intraoperative picrures. Note the dilated ureter above the site of obstruction. This was treated by resection of the stenotic part and reimplantation of the ureter
– |
Long-standing hydronephrosis may be |
– |
Infection |
|
|
associated with obstructive |
nephropathy |
– |
Renal scarring |
|
and renal failure. |
|
– |
Calculus formation |
– |
Patients with complete or |
severe partial |
– |
Sepsis |
bilateral obstruction also may develop |
• |
Hypertension is occasionally induced by renal |
acute or chronic renal failure. |
|
obstruction. |
• Urinary stasis as a result of obstruction may |
• |
The mechanism responsible for the elevation |
be complicated by: |
|
in blood pressure varies with the duration and |
|
|
type of obstruction. |
48 |
2 Hydronephrosis in Infants and Children |
|
|
Figs. 2.10 and 2.11 Two micturating cystourethrograms showing hydrouretronephrosis with dilated urinary bladder secondary to posterior urethral valve. Note the tortuous dilated ureter
DUPLEX URETER
Fig. 2.12 Intraoperative photograph showing an atrophic kidney with dilated refluxing duplex system. Note the markedly dilated duplex ureter
–Acute, unilateral obstruction can cause hypertension via activation of the reninangiotensin system.
–The elevation in blood pressure is probably volume mediated as renin secretion is usually normal in patients with bilateral
urinary tract obstruction or obstruction of a solitary functioning kidney. The elevation in blood pressure resolves with the diuresis following correction of the obstruction.
–The plasma renin activity is also typically normal in chronic unilateral obstruction, and the elevation in blood pressure is unrelated to the renal disease.
•The pathophysiological changes of hydronephrosis depends on several factors which can be summarized as follows:
–Persistent hydronephrosis will lead to the following changes:
•Dilatation of the renal pelvis and the intrarenal collecting system.
•The degree of dilatation is limited by surrounding renal parenchyma.